ASX - By Stock
|
RGT |
Re:
LSE listing
|
|
daphil_1
|
128 |
45K |
3 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
128
|
45K
|
3
|
|
ASX - By Stock
|
RGT |
Re:
LSE listing
|
|
daphil_1
|
128 |
45K |
7 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
128
|
45K
|
7
|
|
ASX - By Stock
|
RGT |
Re:
Ann: MGC Pharma to list on the London Stock Exchange
|
|
daphil_1
|
131 |
53K |
4 |
12/02/21 |
12/02/21 |
ASX - By Stock
|
131
|
53K
|
4
|
|
ASX - By Stock
|
RGT Medicine |
Re:
MGC Pharmaceutical’s (ASX:MGC) ArtemiC combats COVID-19
|
|
daphil_1
|
28 |
15K |
4 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
28
|
15K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Phase II Clinical Trial on Patients Diagnosed with COVID-19
|
|
daphil_1
|
52 |
21K |
10 |
17/04/20 |
17/04/20 |
ASX - By Stock
|
52
|
21K
|
10
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Phase II Clinical Trial on Patients Diagnosed with COVID-19
|
|
daphil_1
|
52 |
21K |
16 |
17/04/20 |
17/04/20 |
ASX - By Stock
|
52
|
21K
|
16
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Phase II Clinical Trial on Patients Diagnosed with COVID-19
|
|
daphil_1
|
52 |
21K |
12 |
17/04/20 |
17/04/20 |
ASX - By Stock
|
52
|
21K
|
12
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Pause In Trade
|
|
daphil_1
|
7 |
3.8K |
2 |
17/04/20 |
17/04/20 |
ASX - By Stock
|
7
|
3.8K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: MGC Pharma Signs Agreement Targeting Anti-Viral Treatments
|
|
daphil_1
|
177 |
69K |
4 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
177
|
69K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
Ann: MGC Pharma Signs Agreement Targeting Anti-Viral Treatments
|
|
daphil_1
|
177 |
69K |
5 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
177
|
69K
|
5
|
|
ASX - By Stock
|
RGT |
Re:
Ann: MGC Pharma Signs Agreement Targeting Anti-Viral Treatments
|
|
daphil_1
|
177 |
69K |
2 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
177
|
69K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: MGC Pharma Signs Agreement Targeting Anti-Viral Treatments
|
|
daphil_1
|
177 |
69K |
4 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
177
|
69K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Suspension from Official Quotation
|
|
daphil_1
|
127 |
58K |
4 |
14/04/20 |
14/04/20 |
ASX - By Stock
|
127
|
58K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Suspension from Official Quotation
|
|
daphil_1
|
127 |
58K |
0 |
14/04/20 |
14/04/20 |
ASX - By Stock
|
127
|
58K
|
0
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Suspension from Official Quotation
|
|
daphil_1
|
127 |
58K |
10 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
127
|
58K
|
10
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Suspension from Official Quotation
|
|
daphil_1
|
127 |
58K |
6 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
127
|
58K
|
6
|
|
ASX - By Stock
|
RGT |
Re:
Ann: MGC Pharma COVID-19 Business and Operations Update
|
|
daphil_1
|
73 |
35K |
9 |
06/04/20 |
06/04/20 |
ASX - By Stock
|
73
|
35K
|
9
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Voluntary Suspension Extension
|
|
daphil_1
|
18 |
7.8K |
8 |
02/04/20 |
02/04/20 |
ASX - By Stock
|
18
|
7.8K
|
8
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Voluntary Suspension Extension
|
|
daphil_1
|
77 |
26K |
2 |
30/03/20 |
30/03/20 |
ASX - By Stock
|
77
|
26K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Voluntary Suspension Extension
|
|
daphil_1
|
18 |
6.4K |
4 |
25/03/20 |
25/03/20 |
ASX - By Stock
|
18
|
6.4K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Voluntary Suspension Extension
|
|
daphil_1
|
18 |
6.4K |
1 |
25/03/20 |
25/03/20 |
ASX - By Stock
|
18
|
6.4K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Voluntary Suspension Extension
|
|
daphil_1
|
33 |
9.4K |
1 |
24/03/20 |
24/03/20 |
ASX - By Stock
|
33
|
9.4K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
MGC media articles
|
|
daphil_1
|
59 |
19K |
12 |
24/03/20 |
24/03/20 |
ASX - By Stock
|
59
|
19K
|
12
|
|
ASX - By Stock
|
RGT |
Re:
MGC media articles
|
|
daphil_1
|
59 |
19K |
0 |
24/03/20 |
24/03/20 |
ASX - By Stock
|
59
|
19K
|
0
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Voluntary Suspension Extension
|
|
daphil_1
|
33 |
9.4K |
2 |
24/03/20 |
24/03/20 |
ASX - By Stock
|
33
|
9.4K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Voluntary Suspension Extension
|
|
daphil_1
|
33 |
9.4K |
3 |
24/03/20 |
24/03/20 |
ASX - By Stock
|
33
|
9.4K
|
3
|
|
ASX - By Stock
|
RGT |
Re:
MGC media articles
|
|
daphil_1
|
59 |
19K |
2 |
24/03/20 |
24/03/20 |
ASX - By Stock
|
59
|
19K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Suspension from Official Quotation
|
|
daphil_1
|
19 |
7.6K |
1 |
23/03/20 |
23/03/20 |
ASX - By Stock
|
19
|
7.6K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Trading Halt
|
|
daphil_1
|
76 |
32K |
1 |
23/03/20 |
23/03/20 |
ASX - By Stock
|
76
|
32K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Trading Halt
|
|
daphil_1
|
76 |
32K |
1 |
22/03/20 |
22/03/20 |
ASX - By Stock
|
76
|
32K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Trading Halt
|
|
daphil_1
|
76 |
32K |
4 |
20/03/20 |
20/03/20 |
ASX - By Stock
|
76
|
32K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Trading Halt
|
|
daphil_1
|
76 |
32K |
5 |
19/03/20 |
19/03/20 |
ASX - By Stock
|
76
|
32K
|
5
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Trading Halt
|
|
daphil_1
|
76 |
32K |
0 |
19/03/20 |
19/03/20 |
ASX - By Stock
|
76
|
32K
|
0
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Trading Halt
|
|
daphil_1
|
76 |
32K |
0 |
19/03/20 |
19/03/20 |
ASX - By Stock
|
76
|
32K
|
0
|
|
ASX - By Stock
|
RGT |
Re:
MGC media articles
|
|
daphil_1
|
59 |
19K |
0 |
18/03/20 |
18/03/20 |
ASX - By Stock
|
59
|
19K
|
0
|
|
ASX - By Stock
|
RGT |
MGC media articles
|
|
daphil_1
|
59 |
19K |
3 |
18/03/20 |
18/03/20 |
ASX - By Stock
|
59
|
19K
|
3
|
|
ASX - By Stock
|
RGT |
Re:
News: MXC MGC Pharmaceuticals Announces Operational Update And Share Purchase Plan Completion
|
|
daphil_1
|
5 |
2.0K |
3 |
17/03/20 |
17/03/20 |
ASX - By Stock
|
5
|
2.0K
|
3
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Operational Update and Share Purchase Plan Completion
|
|
daphil_1
|
8 |
2.6K |
0 |
16/03/20 |
16/03/20 |
ASX - By Stock
|
8
|
2.6K
|
0
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Patients Begin Treatment in Clinical Trial of CogniCann
|
|
daphil_1
|
29 |
10K |
2 |
12/03/20 |
12/03/20 |
ASX - By Stock
|
29
|
10K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Extension of SPP Closing Date
|
|
daphil_1
|
62 |
22K |
2 |
12/03/20 |
12/03/20 |
ASX - By Stock
|
62
|
22K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Extension of SPP Closing Date
|
|
daphil_1
|
62 |
22K |
2 |
12/03/20 |
12/03/20 |
ASX - By Stock
|
62
|
22K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Extension of SPP Closing Date
|
|
daphil_1
|
62 |
22K |
8 |
12/03/20 |
12/03/20 |
ASX - By Stock
|
62
|
22K
|
8
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Extension of SPP Closing Date
|
|
daphil_1
|
62 |
22K |
4 |
12/03/20 |
12/03/20 |
ASX - By Stock
|
62
|
22K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Patients Begin Treatment in Clinical Trial of CogniCann
|
|
daphil_1
|
29 |
10K |
1 |
10/03/20 |
10/03/20 |
ASX - By Stock
|
29
|
10K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Patients Begin Treatment in Clinical Trial of CogniCann
|
|
daphil_1
|
29 |
10K |
2 |
10/03/20 |
10/03/20 |
ASX - By Stock
|
29
|
10K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Patients Begin Treatment in Clinical Trial of CogniCann
|
|
daphil_1
|
29 |
10K |
6 |
09/03/20 |
09/03/20 |
ASX - By Stock
|
29
|
10K
|
6
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Patients Begin Treatment in Clinical Trial of CogniCann
|
|
daphil_1
|
29 |
10K |
7 |
09/03/20 |
09/03/20 |
ASX - By Stock
|
29
|
10K
|
7
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Patients Begin Treatment in Clinical Trial of CogniCann
|
|
daphil_1
|
29 |
10K |
3 |
09/03/20 |
09/03/20 |
ASX - By Stock
|
29
|
10K
|
3
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Patients Begin Treatment in Clinical Trial of CogniCann
|
|
daphil_1
|
29 |
10K |
10 |
09/03/20 |
09/03/20 |
ASX - By Stock
|
29
|
10K
|
10
|
|
ASX - By Stock
|
RGT |
Re:
knock knock
|
|
daphil_1
|
1.0K |
709K |
5 |
08/03/20 |
08/03/20 |
ASX - By Stock
|
1.0K
|
709K
|
5
|
|